Luan Y - Search Results

1

Tumor lysates-constructed hydrogel to potentiate tumor immunotherapy.

Chen X, Jiang Z, Lin Y, Yu C, Nie X, Xu G, Xu W, Jiang Y, Luan Y. Chen X, et al. Among authors: luan y. J Control Release. 2023 Jun;358:345-357. doi: 10.1016/j.jconrel.2023.05.005. Epub 2023 May 11. J Control Release. 2023. PMID: 37150404

2

Functionalized mesoporous silica particles for application in drug delivery system.

Pang J, Luan Y, Yang X, Jiang Y, Zhao L, Zong Y, Li Z. Pang J, et al. Among authors: luan y. Mini Rev Med Chem. 2012 Jul;12(8):775-88. doi: 10.2174/138955712801264855. Mini Rev Med Chem. 2012. PMID: 22512562 Review.

3

Huperzine A-phospholipid complex-loaded biodegradable thermosensitive polymer gel for controlled drug release.

Cai X, Luan Y, Jiang Y, Song A, Shao W, Li Z, Zhao Z. Cai X, et al. Among authors: luan y. Int J Pharm. 2012 Aug 20;433(1-2):102-11. doi: 10.1016/j.ijpharm.2012.05.009. Epub 2012 May 11. Int J Pharm. 2012. PMID: 22583846

4

Formation of drug/surfactant catanionic vesicles and their application in sustained drug release.

Jiang Y, Li F, Luan Y, Cao W, Ji X, Zhao L, Zhang L, Li Z. Jiang Y, et al. Among authors: luan y. Int J Pharm. 2012 Oct 15;436(1-2):806-14. doi: 10.1016/j.ijpharm.2012.07.053. Epub 2012 Jul 31. Int J Pharm. 2012. PMID: 22871561

5

Cytarabine-AOT catanionic vesicle-loaded biodegradable thermosensitive hydrogel as an efficient cytarabine delivery system.

Liu J, Jiang Y, Cui Y, Xu C, Ji X, Luan Y. Liu J, et al. Among authors: luan y. Int J Pharm. 2014 Oct 1;473(1-2):560-71. doi: 10.1016/j.ijpharm.2014.07.032. Epub 2014 Jul 24. Int J Pharm. 2014. PMID: 25066076

6

Design of an Amphiphilic iRGD Peptide and Self-Assembling Nanovesicles for Improving Tumor Accumulation and Penetration and the Photodynamic Efficacy of the Photosensitizer.

Jiang Y, Pang X, Liu R, Xiao Q, Wang P, Leung AW, Luan Y, Xu C. Jiang Y, et al. Among authors: luan y. ACS Appl Mater Interfaces. 2018 Sep 19;10(37):31674-31685. doi: 10.1021/acsami.8b11699. Epub 2018 Sep 5. ACS Appl Mater Interfaces. 2018. PMID: 30133254

7

A preclinical evaluation of cytarabine prodrug nanofibers assembled from cytarabine-lauric acid conjugate toward solid tumors.

Liu R, Jiang Y, Hu X, Wu J, Jiang W, Jin G, Luan Y. Liu R, et al. Among authors: luan y. Int J Pharm. 2018 Dec 1;552(1-2):111-118. doi: 10.1016/j.ijpharm.2018.09.043. Epub 2018 Sep 27. Int J Pharm. 2018. PMID: 30268848

8

A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.

He W, Jiang Y, Li Q, Zhang D, Li Z, Luan Y. He W, et al. Among authors: luan y. Acta Biomater. 2019 Jan 15;84:356-366. doi: 10.1016/j.actbio.2018.11.049. Epub 2018 Nov 29. Acta Biomater. 2019. PMID: 30502480

9

A Three-in-One Immunotherapy Nanoweapon via Cascade-Amplifying Cancer-Immunity Cycle against Tumor Metastasis, Relapse, and Postsurgical Regrowth.

Li Q, Zhang D, Zhang J, Jiang Y, Song A, Li Z, Luan Y. Li Q, et al. Among authors: luan y. Nano Lett. 2019 Sep 11;19(9):6647-6657. doi: 10.1021/acs.nanolett.9b02923. Epub 2019 Aug 19. Nano Lett. 2019. PMID: 31409072

10

Task-Specific Design of Immune-Augmented Nanoplatform to Enable High-Efficiency Tumor Immunotherapy.

Zhang J, Zhang D, Li Q, Jiang Y, Song A, Li Z, Luan Y. Zhang J, et al. Among authors: luan y. ACS Appl Mater Interfaces. 2019 Nov 20;11(46):42904-42916. doi: 10.1021/acsami.9b13556. Epub 2019 Nov 8. ACS Appl Mater Interfaces. 2019. PMID: 31657540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,469 results

Search Page

Filters